Jin Medical International Ltd Quick Ratio (ZJYL) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Jin Medical International Ltd  (ZJYL)

Jin Medical International Ltd's Quick Ratio

ZJYL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2025, Quick Ratio fell to 1.25 above Jin Medical International Ltd average.

Within Medical Equipment & Supplies industry 99 other companies have achieved higher Quick Ratio than Jin Medical International Ltd in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from to 1559.

Explain Quick Ratio?
How much Cash & cash equivalents ZJYL´s has?
What are ZJYL´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZJYL Quick Ratio (Sep 30 2025)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Sep 30 2024)
Q4
Y / Y Current Liabilities Change 61.07 % 123.81 % 166.64 % 120.07 % 65.55 %
Y / Y Cash & cash equivalent Change 10.74 % 14.02 % 203.31 % 85.39 % 173.91 %
Quick Ratio MRQ 1.25 1.26 1.25 1.51 1.81
ZJYL's Total Ranking # 1559 # # # #
Seq. Current Liabilities Change 1.23 % -1.21 % 15.7 % 39.22 % 40.66 %
Seq. Cash & cash equivalent Change 0 % 0 % -4.28 % 15.69 % 2.96 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 100
Healthcare Sector # 614
Overall Market # 1559


Quick Ratio Statistics
High Average Low
1.25 1.17 1.09
(Sep 30 2025)   (Sep 30 2023)




Financial Statements
Jin Medical International Ltd's Current Liabilities $ 24 Millions Visit ZJYL's Balance sheet
Jin Medical International Ltd's Cash & cash equivalent $ 30 Millions Visit ZJYL's Balance sheet
Source of ZJYL's Sales Visit ZJYL's Sales by Geography


Cumulative Jin Medical International Ltd's Quick Ratio

ZJYL's Quick Ratio for the trailling 12 Months

ZJYL Quick Ratio

 (Sep 30 2025)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Sep 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth 110.5 % 119.23 % 126 % 134.21 % 210.2 %
Y / Y Cash & cash equivalent TTM Growth 51.3 % 87.99 % 147.82 % 144.43 % 267.72 %
Quick Ratio TTM 1.31 1.42 1.63 1.71 1.82
Total Ranking TTM # 3293 # # # #
Seq. Current Liabilities TTM Growth 10.92 % 18.67 % 27.15 % 25.77 % 15.52 %
Seq. Cash & cash equivalent TTM Growth 2.46 % 3.21 % 21.25 % 18 % 27.3 %

Quick ratio ranking by company, industry and sector >> Back to ZJYL Financial Strength Comparisons >> Go to Compare ZJYL Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q4 2025 to $23.80 millions, cumulative Quick Ratio decreased to 1.31 above the ZJYL average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 193 other companies have achieved higher Quick Ratio than Jin Medical International Ltd. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from to 3293.

Explain Quick Ratio?
How much Cash & cash equivalents ZJYL´s has?
What are ZJYL´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 194
Healthcare Sector # 880
Within the Market # 3293


trailing twelve months Quick Ratio Statistics
High Average Low
1.09 1.09 1.09
(Sep 30 2023)  




Companies with similar Quick Ratio in the quarter ending Sep 30 2025, within Medical Equipment & Supplies Industry Quick RatioSep 30 2025 MRQ Cash & cash equivalentSep 30 2025 MRQ Current Liabilities
Seastar Medical Holding Corp  3.38 $ 13.763  Millions$ 4.066  Millions
Pulmonx Corporation  3.35 $ 76.549  Millions$ 22.878  Millions
Collplant Biotechnologies Ltd  3.20 $ 5.950  Millions$ 1.858  Millions
Glaukos Corp  3.13 $ 273.712  Millions$ 87.516  Millions
Staar Surgical Co  3.13 $ 192.660  Millions$ 61.637  Millions
Co diagnostics Inc   3.10 $ 11.444  Millions$ 3.693  Millions
Neuropace Inc   3.06 $ 60.014  Millions$ 19.607  Millions
Brainsway Ltd   3.01 $ 67.700  Millions$ 22.495  Millions
Inspire Medical Systems inc   2.91 $ 322.592  Millions$ 110.843  Millions
Biolife Solutions Inc   2.91 $ 78.954  Millions$ 27.146  Millions
Neuroone Medical Technologies Corp  2.85 $ 6.570  Millions$ 2.303  Millions
Strata Critical Medical Inc   2.80 $ 76.181  Millions$ 27.220  Millions
Penumbra Inc  2.77 $ 470.296  Millions$ 169.603  Millions
Intuitive Surgical Inc   2.72 $ 4,908.800  Millions$ 1,803.200  Millions
Bluejay Diagnostics Inc  2.68 $ 3.082  Millions$ 1.149  Millions
Regentis Biomaterials Ltd   2.57 $ 7.378  Millions$ 2.874  Millions
Profound Medical Corp   2.50 $ 24.826  Millions$ 9.938  Millions
Mimedx Group Inc   2.46 $ 142.083  Millions$ 57.682  Millions
Beyond Air Inc   2.44 $ 10.695  Millions$ 4.383  Millions
Edwards Lifesciences Corporation  2.42 $ 3,842.000  Millions$ 1,588.000  Millions
Lyra Therapeutics Inc   2.33 $ 22.055  Millions$ 9.480  Millions
Apyx Medical Corp  2.29 $ 25.135  Millions$ 10.978  Millions
Inogen Inc   2.21 $ 123.223  Millions$ 55.852  Millions
Warby Parker Inc   2.12 $ 280.360  Millions$ 132.065  Millions
Hyperfine Inc   2.12 $ 21.564  Millions$ 10.168  Millions
Nephros Inc   2.10 $ 5.171  Millions$ 2.467  Millions
Pulsenmore Ltd   2.09 $ 6.773  Millions$ 3.239  Millions
Trisalus Life Sciences Inc   2.08 $ 22.687  Millions$ 10.910  Millions
Icecure Medical Ltd  1.93 $ 8.897  Millions$ 4.620  Millions
Atricure Inc   1.90 $ 147.865  Millions$ 77.840  Millions

Date modified: 2026-07-07T14:09:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.